Paper6132660
GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system.
Toffano G and 5 others. Brain Res, 1983. Cited by 231 papers, by iCite.
Cite this record
ConductScience Library. GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system. Papers, record 6132660. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6132660
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Corpus Striatum | Major topic |
| G(M1) Ganglioside | Major topic |
| Gangliosides | Major topic |
| Nerve Regeneration | Major topic |
| Receptors, Dopamine | Major topic |
| Substantia Nigra | Major topic |
| Animals | |
| Axons | |
| Dominance, Cerebral | |
| Dose-Response Relationship, Drug | |
| Homovanillic Acid | |
| Neurons | |
| Rats | |
| Rats, Inbred Strains | |
| Tyrosine 3-Monooxygenase |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41489058 | Engineered GM1 Intersects Between Mitochondrial and Synaptic Pathways to Ameliorate ALS Pathology. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41489058 | PubMed |
| 40270964 | Infection of a β-galactosidase-deficient mouse strain with Theiler's murine encephalomyelitis virus reveals limited immunological dysregulations in this lysosomal storage disease. | Front Immunol | 2025 | https://conductscience.org/library/papers/40270964 | PubMed |
| 38542297 | Alpha-Synuclein and GM1 Ganglioside Co-Localize in Neuronal Cytosol Leading to Inverse Interaction-Relevance to Parkinson's Disease. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38542297 | PubMed |
| 37298512 | Ganglioside GM1 and the Central Nervous System. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298512 | PubMed |
| 36345044 | Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine. | Transl Neurodegener | 2022 | https://conductscience.org/library/papers/36345044 | PubMed |
| 36255683 | Functional Impairment of the Nervous System with Glycolipid Deficiencies. | Adv Neurobiol | 2023 | https://conductscience.org/library/papers/36255683 | PubMed |
| 35064857 | Novel insights on GM1 and Parkinson's disease: A critical review. | Glycoconj J | 2022 | https://conductscience.org/library/papers/35064857 | PubMed |
| 34037912 | A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson's disease. | Glycoconj J | 2022 | https://conductscience.org/library/papers/34037912 | PubMed |
| 33867926 | Sialometabolism in Brain Health and Alzheimer's Disease. | Front Neurosci | 2021 | https://conductscience.org/library/papers/33867926 | PubMed |
| 31703585 | Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease. | Mol Neurodegener | 2019 | https://conductscience.org/library/papers/31703585 | PubMed |
| 30077783 | Ganglioside lipids accelerate α-synuclein amyloid formation. | Biochim Biophys Acta Proteins Proteom | 2018 | https://conductscience.org/library/papers/30077783 | PubMed |
| 27520520 | The Therapeutic Role of Gangliosides in Neurological Disorders. | CNS Drugs | 1994 | https://conductscience.org/library/papers/27520520 | PubMed |
| 26099170 | GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding. | J Neurol Sci | 2015 | https://conductscience.org/library/papers/26099170 | PubMed |
| 25762012 | GM1 Ganglioside: Past Studies and Future Potential. | Mol Neurobiol | 2016 | https://conductscience.org/library/papers/25762012 | PubMed |
| 12829403 | Gangliosides prevent excitotoxicity through activation of TrkB receptor. | Neurotox Res | 2002 | https://conductscience.org/library/papers/12829403 | PubMed |
| 12374219 | Association of GPI-anchored protein TAG-1 with src-family kinase Lyn in lipid rafts of cerebellar granule cells. | Neurochem Res | 2002 | https://conductscience.org/library/papers/12374219 | PubMed |
| 11201786 | Functional roles of glycosphingolipids in signal transduction via lipid rafts. | Glycoconj J | 2000 | https://conductscience.org/library/papers/11201786 | PubMed |
| 8619009 | GM1 ganglioside administration partially counteracts the morphological changes associated with haloperidol treatment within the dorsal striatum of the rat. | Psychopharmacology (Berl) | 1995 | https://conductscience.org/library/papers/8619009 | PubMed |
| 8124674 | Monosialoganglioside GM1 blood levels in maternal and newborn umbilical cord blood at birth. | Childs Nerv Syst | 1993 | https://conductscience.org/library/papers/8124674 | PubMed |
| 7586900 | Clinical pharmacokinetics of drugs for Alzheimer's disease. | Clin Pharmacokinet | 1995 | https://conductscience.org/library/papers/7586900 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TH | 7054 | PubTator's text mining | https://conductscience.org/library/genes/7054 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6132660
GET https://conductscience.org/api/papers/v1/6132660/cited_by?page=2